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especially for developing countries. The aim of this study was to assess the association be-
tween breast feeding (BF) and birth weight (BW) with anthropometric measures and blood
pressure (BP) in a nationallyerepresentative sample of Iranian children and adolescents.
Methods: In this national survey, 14,880 children and adolescents, aged 6e18 years, were
selected using a multistage, cluster sampling method from rural and urban areas of 30 prov-
inces of Iran. BF duration and BW were assessed by validated questionnaires completed by par-
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Pediatric Anthropometrics measures and BP 325Results: The study participants were 13,486 students (participation rate of 90.6%). They con-
sisted of 49.24% girls, 75.6% urban residents, with a mean age of 12.5 years (95% confidence
interval: 12.3e12.6). The family history of obesity had a significant association with BW
(p < 0.001). A substantial association was found between BF duration and the order of children
in the family, both in boys (p < 0.001) and girls (p < 0.001). The mean values for height,
weight, body mass index, as well as waist, wrist, and hip circumferences were higher in those
with higher BW categories (p for trend < 0.001). As BW increased, there was a linear decrease
in underweight (p for trend < 0.001) and a linear increase in the prevalence of generalized
obesity (p for trend < 0.001) was documented.
Conclusion: BW was associated with a higher prevalence in general obesity and a lower prev-
alence of being underweight. Duration of BF had no significant association with anthropometric
measures and BP. Future longitudinal studies are necessary to determine the clinical implica-
tions of these findings.
Copyright ª 2015, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Noncommunicable diseases (NCDs) and their risk factors are
major health threats, especially for developing countries.1
Being under- or overweight is associated with an increased
risk of adverse health outcomes such as type 2 diabetes and
cardiovascular diseases (CVDs).2
Obesity and its increasing prevalence are now consid-
ered to be a common health problem both in developed and
developing countries.3 Most obese children and adolescents
are already at high risk of wide health problems.4,5 More-
over, some evidence exists on long-term adverse health
outcomes in adulthood.4,6 Obesity is a multi-factorial dis-
order; genetic, socio-economic status (SES), life style,
physical activity, and food behaviors are important pre-
disposing factors.7
Over the past decade, blood pressure (BP) has increased
among children and adolescents. This increase is partially
attributable to an increased prevalence of being over-
weight.8 The effect of BW and BF on adolescents’ BP re-
mains a controversial debate.9e11
The evaluation of adolescents’ cardiometabolic risk
factors is well documented.1 Therefore; more attention
needs to be directed to designing and conducting metabolic
risk factor studies.1 The present study aimed to estimate
the association between BF and BW with anthropometric
measures and BP in Iranian children and adolescents.
2. Methods
The study participants consisted of a nationally represen-
tative sample of children and adolescents studied in the
fourth national survey of a school-based surveillance sys-
tem entitled “Childhood and Adolescence Surveillance and
Prevention of Adult Noncommunicable Disease” (CASPIAN-
IV) study. It was conducted in 2011e2012 in 30 provinces in
Iran. 14,880 students, aged 6e18 years, were selected from
elementary, middle, and high schools using multistage
cluster sampling method from rural and urban areas (48
clusters of 10 students in each province). The details of the
aim and protocol of this study were published previously.12All processes of measurement with calibrated in-
struments and the recording of information in validated
checklists were followed by trained health care pro-
fessionals. The aim was to achieve the highest quality of
data through the present multi-center data. Gathering
different levels of quality assurance were also supervised
by the Data and Safety Monitoring Board (DSMB) of the
project.12
2.1. Definition of terms
2.1.1. Anthropometric measures and BP
The modified criteria for definition of risk factors in the
pediatric age group were as follows: abdominal obesity as
waist circumference (WC)  90th percentile for age and
sex; and elevated BP as either systolic or diastolic (SBP,
DBP)  90th percentile for age, sex, and height.13,14
Overweight and general obesity were defined based on
the criteria of the Centers of Disease Control and Preven-
tion (CDC), which have been confirmed to be appropriate
for Iranian children and adolescents.15,16 The age- and sex-
specific percentiles of body mass index (BMI) > 95th
percentile were considered as obesity, BMI of > 85th and 
95th percentile as overweight, BMI of > 5th and  85th
percentile as normal weight, and < 5th percentile as
underweight.15
2.2. Breast feeding
In this study, breast feeding (BF) refers to BF that includes
the whole month that participants were breast fed. For
example, when Table 1 presents the duration of BF, not
“exclusive breastfeeding” means the participant consumed
other foods, in addition to having been breast fed.
For comparative analyses, BF duration (month) was
categorized into five groups of 0 months, < 6 months, >
6e12 months, > 12e18 months, and > 18e24 months.
Table 1 presents the duration of “ever breastfeeding”,
but not “exclusive breastfeeding”, so in some periods while
the infant was breastfed, he/she also consumed other
foods.
Table 1 General characteristics of participants according to breast feeding duration and birth weight categories: The CAS AN-IV study.
BF duration (mo) BW (g)
0  6 > 6e12 > 12e18 > 18e24 p < 25 2500e4000 > 4000 p
Age (y), Mean (95%CI)a 12.42 (11.93, 12.91) 12.44 (12.17, 12.71) 12.86 (12.58, 13.14) 12.53 (12.26, 12.80) 12.40 (12.19, 12.61) 0.200 12.34 2.06, 12.61) 12.30 (12.12, 12.48) 12.48 (12.18, 12.78) 0.932
Living place
Urban 2.41 (2.1, 2.77) 29.27 (27.62, 30.98) 10.92 (10.09, 30.98) 12.26 (11.46, 13.1) 45.14 (43.49, 46.79) 0.0294 8.6 .03, 9.3) 83.13 (82.23, 83.99) 8.22 (7.58, 8.92) 0.001**
Rural 1.49 (1.09, 2.05) 25.83 (22.63, 29.3) 10.32 (8.94, 11.88) 12.85 (11.27 14.61) 49.51 (46.26, 52.77) 9.66 .44, 11.02) 84.57 (82.87, 86.13) 5.77 (4.87, 6,84)
Sex
Boy 2.07 (1.71, 2.51) 28.76 (26.71, 30.90) 10.58 (9.58, 11.67) 11.45 (10.5, 12.46) 47.14 (43.03, 49.27) 0.202 8.58 .82, 9.42) 82.7 (81.58, 83.78) 8.71 (7.92, 9.58) 0.001**
Girls 2.31 (1.94, 2.75) 28.12 (25.98, 30.36) 10.97 (9.98, 12.05) 13.38 (12.32, 14.52) 45.22 (43.15, 47.3) 9.2 .42, 10.05) 84.27 (83.16, 85.31) 6.53 (5.82, 7.33)
Family history of
Diabetes
Yes 2.23 (1.83, 2.71) 30.55 (28.75, 32.40) 10.97 (9.92, 12.13) 12.38 (11.34, 13.5) 43.88 (42.03, 45.74) 0.001** 8.98 .14, 9.90) 82.59 (81.39e83.74) 8.42 (7.6, 9.33) 0.0412
No 2.11 (1.79, 2.48) 27.14 (25.59, 28.76) 10.77 (9.92, 11.68) 12.42 (11.56, 13.33) 47.56 (45.91,49.23) 8.71 .01, 9.46) 84.13 (83.14e85.08) 7.16 (6.52, 7.85)
Obesity
Yes 2.32 (1.95, 2.75) 30.06 (28.35, 31.83) 11.14 (10.21, 12.13) 12.18 (11.24, 13.17) 44.31 (42.56, 46.08) 0.001** 9.12 .32, 9.98) 82.21 (81.1, 83.27) 8.67 (7.91, 9.49) 0.001**
No 2.07 (1.73, 2.48) 27.18 (25.55, 28.88) 10.50 (9.61,11.46) 12.63 (11.72, 13.59) 47.62 (45.93, 49.31) 8.66 .95,9.42) 84.6 (83.60, 85.56) 6.74 (6.08, 7.46)
Dyslipidemia
Yes 2.34 (1.96, 2.80) 29.41 (27.73, 31.15) 11.2 (10.2, 12.29) 12.26 (11.32, 13.26) 44.78 (43.03, 46.55) 0.01* 8.98 .22, 9.80) 82.39 (81.29, 83.44) 8.63 (7.86, 9.47) 0.001
No 2.06 (1.74, 2.44) 27.64 (26.04, 29.30) 10.42 (9.60, 11.31) 12.59 (11.7, 13.55) 47.28 (45.62, 48.95) 8.73 .01, 9.52) 84.45 (83.44, 85.41) 6.82 (6.19, 7.50)
Hypertension
Yes 2.20 (1.86, 2.59) 30.04 (28.42, 31.72) 10.70 (9.83, 11.64) 12.06 (11.2, 12.98) 44.99 (43.34, 46.66) 0.001** 9.18 .47, 9.95) 82.84 (81.82, 83.82) 7.97 (7.27, 8.74) 0.0923
No 2.15 (1.80, 2.58) 26.5 9 (24.93, 28.32) 10.86 (9.95, 11.85) 12.8 (11.84, 13.82) 47.59 (45.82, 49.37) 8.46 .69, 9.30) 84.35 (83.24, 85.40) 7.19 (6.49, 7.96)
Birth order
1st 2.51 (2.11, 2.98) 30.18 (28.45, 31.97) 10.4 (9.5, 11.38) 13.03 (12.05, 14.07) 43.88 (42.12, 45.66) 0.001** 8.28 .53, 9.09) 84.98 (83.91, 85.99) 6.74 (6.02, 7.54) 0.01*
2nd 1.9 (1.48, 2.44) 30.05 (28.08, 32.1) 10.48 (9.39, 11.69) 12.55 (11.39, 13.81) 45.01 (42.97, 47.07) 9.06 .11, 10.11) 82.75 (81.38, 84.04) 8.18 (7.28, 9.19)
3rd 1.86 (1.33, 2.59) 25.11 (22.84, 27.53) 11.15 (9.7, 12.79) 11.37 (9.94, 12.99) 50.51 (47.96, 53.05) 9.2 .89, 10.7) 81.72 (79.7, 83.57) 9.08 (7.77, 10.58)
 4th 2.17 (1.62, 2.91) 24.73 (22.45, 27,17) 11.97 (910.46, 13.68) 11.51 (10.07, 13.13) 49.61 (46.97, 52.24) 9.98 .61, 11.54) 82.03 (80.04, 83,86) 7.99 (6.8, 9.37)
Family size
 4 person 2.49 (2.13, 2.92) 30.32 (28.62, 32.06) 9.94 (9.1, 10.85) 12.37 (11.46, 13.34) 44.89 (43.17, 46.61) 0.001** 7.94 .25, 8.68) 84.55 (83.59, 85.48) 7.51 (6.84, 8.24) 0.001**
> 4 person 1.91 (1.57, 2.32) 26.74 (25.08, 28.47) 11.52 (10.55, 12.57) 12.37 (11.42, 13.38) 47.46 (45.69, 49.23) 9.88 .07, 10.75) 82.26 (81.08, 83.37) 7.87 (7.1, 8.71)
Watching TV
 2 h/d 2.39 (2.01, 2.82) 27.37 (25.7, 29.11) 10.29 (9.4, 11.26) 12.25 (11.33, 13.22) 47.4 (45.95, 49.46) 0.001** 9.14 .37, 9.98) 83.43 (82.32, 84.48) 7.43 (6.71, 8.22) 0.519
> 2 h/d 2.02 (1.67, 2.44) 29.47 (27.83, 31.16) 11.18 (10.26, 12.15) 12.5 (11.58, 13.48) 44.84 (43.15, 46.54) 8.65 .93, 9.43) 83.55 (82.52, 84.52) 7.8 (7.11, 8.56)
Working computer
 2 h/d 2.2 (1.92, 2.51) 28.67 (27.21, 30.18) 10.53 (9.79, 11.32) 12.52 (11.76, 13.31) 46.08 (44.61, 47.56) 0.203 9.01 .41, 9.65) 83.62 (82.78, 84.43) 7.37 (6.81, 7.98) 0.001**
> 2 h/d 1.99 (1.31, 3.03) 28.07 (25.2, 31.14) 12.71 (10.83, 14.85) 11.13 (9.34, 13.21) 46.1 (42.87, 49.35) 7.16 .82, 8.77) 83.48 (81.17, 85.56) 9.36 (7.73, 11.31)
Screen time
 2 h/d 2.23 (1.94, 2.56) 28.26 (26.78, 29.8) 10.5 (9.74, 11.31) 12.52 (11.75, 13.33) 46.49 (44.98, 48.01) 0.286 9.08 .45, 9.74) 83.54 (82.68, 84.37) 7.38 (6.81, 8.73) 0.069




























Mild 2.6 (2.16, 3.13) 28.25 (26.18, 30.42) 11.32 (10.29, 12.42) 12.64 (11.51, 13.86) 45.19 (43.05, 47.35) 0.01* 9.1 (8.18, 10.12) 82.37 (81.02, 83.64) 8.53 (7.6, 9.55) 0.001**
Moderate 1.9 (1.53, 2.36) 27.14 (25.34, 29.01) 10.89 (9.88, 11.98) 12.92 (11.83, 14.09) 47.16 (45.24, 49.08) 8.31 (7.5, 9.2) 83.93 (82.71, 85.09) 7.75 (6.91, 8.69)
Severe 2.11 (1.67, 2.66) 30.55 (28.33, 32.87) 9.91 (8.7, 11.26) 11.34 (10.21, 12.58) 46.09 (43.82, 48.37) 9.34 (8.35, 10.43) 84.24 (8.29, 85.49) 6.43 (5.64, 7.32)
Sleeping h/wk
< 5h 0 33.33 (23.89, 44.33) 12.35 (6.86, 21.23) 13.58 (7.79, 22.63) 40.74 (30.46, 51.9) 0.678 7.58 (3.23, 16.77) 86.36 (75.82, 92.75) 6.06 (2.28, 15.16) 0.175
5e8 2.43 (1.92, 3.07) 28.99 (26.75, 31.33) 10.95 (9.7, 12.33) 11.64 (10.46, 12.94) 45.99 (43.64, 48.35) 9.09 (8, 10.32) 82.22 (80.65, 83.69) 8.69 (7.61, 9.9)
> 8 2.15 (1.86, 2.49) 28.21 (26.71, 29.76) 10.68 (9.9, 11.51) 12.53 (11.73, 13.38) 46.43 (44.9, 47.96) 8.84 (8.21, 9.51) 83.88 (83, 84,72) 7.28 (6.69, 7.92)
Socioeeconomic status
Low 2.51 (2.02, 3.1) 25.18 (23.01, 27.47) 10.53 (9.43, 11.74) 12.24 (11.08, 13.52) 49.54 (47.25, 51.83) 0.001** 11.25 (10.11, 12.51) 83.15 (81.67, 84.53) 5.6 (4.82, 6.5) 0.001**
Intermediate 2.07 (1.64, 2.6) 28.86 (26.92, 30.88) 10.31 (9.25, 11.48) 13.63 (12.44, 14.91) 45.14 (43.12, 47.17) 8.34 (7.46, 9.31) 83.43 (82.13, 84.66) 8.23 (7.36, 9.19)
High 2.19 (1.76, 2.72) 30.99 (28.91, 33.14) 11.32 (10.1, 12.66) 11.59 (10.53, 12.75) 43.91 (41.79, 46.06) 6.98 (6.17, 7.89) 84.46 (83.14, 85.69) 8.56 (7.6, 9.63)
Type of complementary feeding
aAlways homemade foods 2 (1.71, 2.33) 26.14 (24.62, 27.72) 10.01 (9.26, 10.82) 12.29 (11.47, 13.16) 49.56(47.97, 51.15) 0.001** 8.78 (8.15, 9.45) 84.04 (83.12, 84.92) 7.18 (6.56, 7.86) 0.001**
bAlways formula 2.95 (1.76, 4.93) 40.23 (934.95, 45.74) 16.14 (12.77, 20.19) 10.23 (7.7, 13.46) 30.45 (25.88, 35.45) 13.91 (10.64, 17.99) 74.02 (69.05, 78.43) 12.07 (9.08, 15.89)
Usually homemade foods 2.6 (2.02, 3.33) 33.13 (30.7, 35.65) 12.18 (10.79, 13.71) 13.44 (12.08, 14.92) 38.66 (36.28, 41.1) 7.84 (6.78, 9.04) 83.72 (82.18, 85.15) 8.44 (7.4, 9.61)
Usually formula 3.51 (2, 6.09) 37.13 (31.85, 42.75) 14.62 (10.23, 20.47) 11.11 (8.04, 15.16) 33.63 (28.01, 39.74) 11.11 (7.91, 15.38) 80.07 (74.93, 84.37) 8.82 (6.02, 12.76)
Type of milk consumed
Breast feeding 0 22.71 (21.18, 24.32) 9.71 (8.97, 10.51) 13.6 (12.78, 14.46) 53.98 (52.37, 55.58) 0.001** 7.32 (6.78, 7.9) 85.02 (84.19, 85.82) 7.66 (7.06, 8.3) 0.001**
Formula 40.69 (36.17, 45.37) 45.34 (40.89, 49.87) 4.25 (2.8, 6.41) 2.63 (1.54, 4.47) 7.09 (4.97, 10.01) 19.1 (15.85, 22.85) 73.29 (69.24, 76.99) 7.6 (5.58, 10.27)
Cow’s milk 3.44 (2.53, 4.66) 58.17 (55.04, 61.23) 18.1 (15.82, 20.62) 8.57 (7.05, 10.39) 11.72 (9.88, 13.96) 15.5 (13.47, 17.77) 78.59 976.12, 80.86) 5.91 (4.77, 7.3)
Mixed 4.03 (2.45, 6.57) 57.26 (51.88, 62.47) 23.66 (19.51, 28.37) 6.45 (4.38, 9.41) 8.6 (6.1, 12) 11.92 (8.78, 15.98) 73.84 (68.73, 78.37) 14.24 (10.66, 18.77)
* Significantly different from > 18e24 month, p Z 0.003.
** Significantly different from > 18e24 month, p Z 0.02.
CASPIAN Z Childhood and Adolescence Surveillance and Prevention of Adult Noncommunicable Disease.
a Use of homemade foods but sometimes formula.
b Use of formula but sometimes homemade foods.
Table 2 Mean (95% CI) of anthropometric indices and blood pressure (BP) level in breast feeding (BF) duration and birth weight (BW) categories: the CASPIAN-IV study.
BF duration (mo) BW categories (g)
0  6 > 6e12 > 12e18 > 18e24 p
trend
< 2500 2500e4000 > 4000 p
trend
Weight (kg) 40.93 (38.62, 43.23) 42.62 (41.15, 43.78) 44.15 (42.77, 45.53) 42.29 (41.06, 43.52) 42.10 (41.19, 43.02) 0.362 39.96 (38.73, 41.18) 41.95 (41.17, 42.74) 45.46 (43.89, 47.02) 0.001*
Height (cm) 146.07 (143.80, 148.34) 147.13 (145.72, 148.53) 148.87 (147.38, 150.37) 147.07 (145.70, 148.45) 146.67 (145.60, 147.74) 0.424 144.79 (143.40, 146.19) 146.40 (145.48, 147.32) 149.13 (147.54, 150.72) 0.001*
BMI (kg/m2) 18.39 (17.80, 18.98) 18.91 (18.68, 19.14) 19.20 (18.90, 19.51) 18.8 (18.54, 19.08) 18.79 (18.61, 18.97) 0.402 18.29 (18, 18.58) 18.80 (18.64, 18.95) 19.64 (19.29, 19.99) 0.001*
WC (cm) 66.11 (64.59, 67.62) 66.87 (66.15, 67.60) 68.16 (67.33, 69.0) 66.67 (65.84, 67.50) 67.07 (66.53, 67.62) 0.809 65.83 (65.02, 66.65) 66.87 (66.39, 67.34) 69.28 (68.27, 70.29) 0.001*
WHtR 42.28 (44.53, 46.04) 45.54 (45.25, 45.84) 45.83 (45.46, 46.20) 45.14 (45, 45.82) 45.81 (45.54, 46.03) 0.130 45.54 (45.15, 45.94) 45.75 (45.56, 45.93) 46.51 (46.03, 46.98) 0.609
Wrist (cm) 14.48 (14.23, 14.72) 14.75 (14.63, 14.88) 14.94 (14.77, 15.11) 14.76 (14.63, 14.89) 14.76 (14.67, 14.85) 0.884 14.46 (14.32, 14.60) 14.72 (14.64, 14.80) 15.11 (14.96, 15.78) 0.001*
Hip (cm) 80.16 (78.33, 81.98) 80.68 (79.72, 81.63) 82.04 (80.56, 83.52) 80.47 (79.42, 81.52) 80.85 (80.10, 81.60) 0.946 79.41 (78.38, 80.44) 80.42 (79.78, 81.06) 83.13 (81.88, 84.38) 0.001*
WhtR 18.22 (17.99, 18.46) 18.61 (18.36, 18.85) 18.61 (18.38, 18.83) 18.73 (18.42, 19.05) 18.57 (18.45, 18.68) 0.978 18.51 (18.32, 18.71) 18.64 (18.51, 18.780 18.56 (18.26, 18.860 0.683
SBP (mmHg) 99.42 (97.86, 100.99) 101.59 (100.81, 102.37) 102.74 (101.80, 103,69) 101.36 (100.47, 102.24) 101.35 (100.71, 101.99) 0.663 100.52 (99.61, 101.42) 101.28 (100.76, 101.80) 102.49 (101.36, 103.62) 0.003
DBP (mm Hg) 63.73 (62.33, 65.13) 64.92 (64.25, 65.58) 65.75 (64.92, 66.58) 64.52 (63.74, 65.30) 64.74 (64.21, 65,27) 0.609 64.35 (63.53, 65.18) 64.73 (64.28, 65.17) 65.32 (64.43, 66.21) 0.083
BMI Z body mass index; DBP Z diastolic blood pressure; SBP Z systolic blood pressure; WC Z waist circumference; WHtR Z waist to height ratio; WhtR Z waist to hip ratio.
* Significantly different from > 18e24 month, p Z 0.02.
CASPIAN Z Childhood and Adolescence Surveillance and Prevention of Adult Noncommunicable Disease.
Table 3 Prevalence (95% CI) of obesity, overweight, abdominal obesity and blood pressure (BP) categories in breast feeding (BF) duration and birth weight (BW) categories: the
CASPIAN-IV study.
BF duration (mo) BW categories (g)
0  6 > 6e12 > 12e18 > 18e24 p trend < 2500 2500e4000 >4000 p trend
Underweight 14.75 (11.15, 19.250 11.88 (10.69, 13.18) 11.04 (9.36, 12.98) 12.97 (11.35, 14.78) 12 (11.06, 13.02) 0.994 15.85 (13.67, 18.31) 12 (11.25, 12.8) 7.97 (6.39, 9.9) 0.001*
Overweight 6.47 (4.04, 10.21) 9.46 (8.57, 10.43) 10.08 (8.55, 11.85) 9.6 (8.22, 11.19) 9.92 (9.14, 10.75) 0.243 8.35 (6.87, 10.11) 9.77 (9.17, 10.41) 12.23 (10.26, 14.5 0.004
General obesity 10.07 (6.82, 14.63) 12.99 (11.79, 14.31) 12.14 (10.46, 14.05) 11.32 (9.75, 13.1) 11.39 (10.48, 12.36) 0.071 9.38 (7.73, 11.34) 12.12 (11.35, 12.93) 16.92 (14.65, 19.46) 0.001*
Abdominal
obesity
16.13 (12.10,21.17) 18.99 (17.51,20.57) 20(17.94,22.23) 17.77 (15.84, 19.87) 19.49(18.22,20.83) 0.519 19.03(16.7, 21.6) 19.26(18.25,20.30) 24.27(21.56,27.20) 0.007
High SBP 0.72 (0.18, 2.83) 0.78 (0.45, 1.34), 1.17 (0. 7, 1.96) 0.76 (0.42, 1.39) 0. 97 (0. 73, 1.3) 0.561 1.31 (1, 2.350 0.81 (0.63, 1.05) 1 (0, 2) 0.460
High DBP 2.15 (0.97, 4.68) 3.36 (2.41, 4.67) 3.59 (2.55, 5.03) 2.86 (1.93, 4.22) 2.87 (2.33, 3.52) 0.429 3 (2.0, 4.45) 2.94 (2.43, 3.55) 3.15 (2.16, 4.58) 0.863
HTN 2.51 (1.21, 5.13) 3.89 (2.88, 5.24) 4.32 (3.18, 5.84) 3.81 (2.76, 5.24) 3.53 (2.94, 4.23) 0.638 3.56 (2.47, 5.11) 3.57 (3.02, 4.22) 3.8 (2.67, 5.4) 0.797
DBP Z diastolic blood pressure; HTN Z hypertension; SBP Z systolic blood pressure.
* Significantly different from > 18e24 month, p Z 0.02.
CASPIAN Z Childhood and Adolescence Surveillance and Prevention of Adult Noncommunicable Disease.
Pediatric Anthropometrics measures and BP 3292.2.1. Birth weight
Participants’ birth weight (BW; g) was categorized into




Height (Ht) and weight (Wt) were measured by trained
research assistants, according to standardized protocols,
without shoes and with light clothing to the nearest 0.1 unit
of measure (cm for Ht and kg for Wt). As a measure of
obesity, BMI was calculated as Wt (kg) divided by Ht
squared (m2).14,17 WC was measured over the skin, midway
between the lower border of the rib margin and the iliac
crest at the end of normal expiration, to the nearest
0.1 cm. Both WC and Ht were measured using nonelastic
tapes.11,15
2.3.2. Blood pressure
SBP and DBP were measured, using standardized mercury
sphygmomanometers, on the right arm after a 15 minute
rest in a sitting position. The first and fifth Korotkoff sounds
were recorded as SBP and DBP, respectively. After 5 minute
intervals, BP was measured for a second time and the
average of two measurements was considered as the actual
value.12,18
2.4. Demographic information
Two sets of standardized questionnaires were completed by
students and their parents. Demographic information
regarding family history of chronic diseases (hypertension,
dyslipidemia, diabetes, and obesity), parental level of ed-
ucation (the highest total years of schooling), ownership of
a family private car and type of home, dietary habits, life-
style habits, physical activity pattern, and sedentary life-
style), was collected by trained interviewers for all par-
ticipants through interview with parents or children in a
calm atmosphere inside the schools.
2.5. Statistical analyses
Categorical variables are presented as a percentage with
95% confidence interval (CI). Mean of continuous variables
are summarized with 95% CI.
Comparisons of continuous and categorical variables
across BF and BW categories were assessed by using analysis
of variance (ANOVA) and Pearson Chi-square tests. Logistic
regression analyses were used to evaluate the association
between BF duration and BW categories with anthropo-
metric measurements and BP in different models, adjusting
for possible confounders. Model I is a crude model (without
adjustment). In Model II, the association was adjusted for
age, sex, and living place, and in Model III, family history of
chronic diseases, screen time, physical activity, SES, birth
order, family size, type of complementary feeding, type of
milk consumed in infancy, sleeping hours, BMI, and
elevated BP were additionally adjusted. In Model IV, addi-
tional adjustment was considered for BF duration and BW
categories.Statistical measures were estimated using survey data
analysis methods. Data were analyzed by using STATA
package Corp. 2011 (Stata Statistical Software, Release 12.
Stata Corp LP, College Station, TX, USA). A p value < 0.05
was considered as statistically significant.
2.6. Ethical consideration
The study was reviewed and approved by ethical commit-
tees and other relevant regulatory organizations at national
and provincial levels. The process of sampling and exami-
nation began after explaining the project to the students
and their parents. Participation in the study was voluntary.
Written informed consent and verbal consent were ob-
tained from parents and students, respectively.
3. Results
Overall, 13,486 students completed the study (participation
rate of 90.6%). They consisted of 49.24% girls, 75.6% urban
residents, with a mean age of 12.5 years (95% CI:
12.3e12.6). The general characteristics of study partici-
pants according to BF duration and BW categories are
presented in Table 1.
Compared to boys, the number of girls was higher in the
first (< 2500 g) and second (2500e4000 g) categories of BW
(p < 0.001). Family history of obesity had a significant as-
sociation with BW (p < 0.001). Overall, 82.21% (95% CI:
81.1e83.27) of participants with BW of 2500e4000 g had a
positive family history of obesity, which was significantly
higher than the two BW categories.
We found a significant association between BW cate-
gories and living place (p < 0.001). Low BW was more
prevalent in rural areas [9.66 (8.44e11.02) vs. 8.65
(8.03e9.3)]. Regarding the family history of chronic dis-
eases; family history of obesity had a significant association
with BW (p < 0.001). There was no significant association
between BF duration and family history of chronic disease.
SBP and DBP had no significant association with BF duration
and BW.
As presented in Table 1, a significant association was
found between BF duration and the order of children in the
family, both in boys (p < 0.001) and girls (p < 0.001).
Likewise, the family size had a significant association with
both BF duration (p < 0.001) and BW (p < 0.001).
The distribution of the participants in different cate-
gories of BF duration and BW groups had a significant as-
sociation with SES categories (p < 0.001), the type of
complementary feeding (p < 0.001), and the type of milk
consumed during infancy (p < 0.001).
All participants had a history of breast feeding, which
was categorized in to five time duration groups. Analysis of
data from 10,502 participants, shows that 53.98%
(nZ 5669) had 18e24 months duration of BF. Respectively,
13.6% (n Z 1428) were breast fed for 12e18 months and
9.7% (n Z 1020) for 6e12 months. Whereas for 22.7%
(nZ 2385) of participants, time duration of BF was up to 6
months.
Mean (95% CI) anthropometric indices and BP in cate-
gories of BF duration and BW are presented in Table 2. The
mean values for Ht, Wt, BMI, WC, wrist, and hip
Table 4 Odds ratios (95% CIs) for underweight, obesity, overweight, abdominal obesity, and blood pressure categories in breast feeding duration and birth weight categories:
The CASPIAN-IV study.
BF duration (mo) BW categories (g)
0  6 > 6e12 > 12e18 > 18e24 p trenda < 2500 2500e4000 > 4000 p trenda
Underweight
Model Ib 1 0.78 (0.56, 1.09) 0.71 (0.50, 1.04) 0.86 (0.60, 1.23) 0.79 (0.56, 1.10) 0.994 1 0.72 (0.60, 0.87)* 0.46 (0.34, 0.61)* 0.001**
Model IIc 1 0.76 (0.54, 1.07) 0.71 (0.49, 1.02) 0.84 (0.59, 1.20) 0.76 (0.54, 1.06) 0.799 1 0.73 (0.61, 0.87)* 0.47 (0.35, 0.63)* 0.001**
Model IIId 1 0.66 (0.47, 0.94) 0.60 (0.41, 0.88) 0.71 (0.49, 1.03) 0.67 (0.47, 0.95) 0.762 1 0.78 (0.64, 0.95) 0.51 (0.37, 0.71)* 0.001**
Model IVe 1 0.71 (0.49, 1.05) 0.69 (0.45, 1.06) 0.79 (0.52, 1.19) 0.75 (0.52, 1.10) 0.729 1 0.78 (0.64, 0.95) 0.53 (0.38, 0.73)* 0.001**
Overweight
Model Ib 1 1.51 (0.90, 2.52) 1.62 (0.96, 2.73) 1.53 (0.91, 2.58) 1.59 (0.96, 2.63) 0.243 1 1.19 (0.95, 1.48) 1.53 (1.15, 2.03) 0.004
Model IIc 1 1.55 (0.93, 2.60) 1.65 (0.97, 2.79) 1.59(0.94, 2.68) 1.67 (1.00, 2.77) 0.128 1 1.18 (0.94, 1.48) 1.48 (1.11, 1.97) 0.008
Model IIId 1 1.69 (0.93, 3.07) 1.82 (0.99, 3.35) 1.86 (1.02, 3.40) 1.82 (1.01, 3.26) 0.130 1 1.20 (0.94, 1.54) 1.43 (1.04, 1.97) 0.028
Model IVe 1 0.49 (0.13, 1.11) 0.53 (0.11, 1.17) 0.55 (0.07, 1.18) 0.56 (0.05, 1.17) 0.177 1 1.20 (0.93, 1.55) 1.42 (1.02, 1.99) 0.039
General obesity
Model Ib 1 1.33 (0.86, 2.07) 1.23 (0.79, 1.93) 1.14 (0.72, 1.79) 1.15 (0.74, 1.77) 0.171 1 1.33 (1.07,1.65) 1.97 (1.50, 2.59)* 0.001**
Model IIc 1 1.37 (0.88, 2.12) 1.29 (0.83, 2.02) 1.21 (0.77, 1.90) 1.20 (0.78, 1.84) 0.129 1 1.32 (1.06, 1.64) 1.86 (1.41, 2.44)* 0.001**
Model IIId 1 1.70 (1.03, 2.82) 1.58 (0.94, 2.66) 1.41 (0.83, 2.38) 1.45 (0.88, 2.39) 0.116 1 1.34 (1.05, 1.71) 1.72 (1.26, 2.34)* 0.001**
Model IVe 1 1.53 (0.91, 2.56) 1.37 (0.81, 2.33) 1.25 (0.73, 2.14) 1.33 (0.80, 2.22) 0.206 1 1.30 (1.01, 1.66) 1.67 (1.22, 2.29)* 0.001**
Abdominal adiposity
Model Ib 1 1.22 (0.86, 1.73) 1.3 (0.91, 1.85) 1.12 90.78, 1.61) 1.26 (0.89, 1.77) 0.526 1 1.01 (0.86, 1.19) 1.36 (1.10, 1.69) 0.007
Model IIc 1 1.25 (0.88, 1.78) 1.35 (0.94, 1.92) 1.18 (0.82, 1.70) 1.32 (0.94, 1.86) 0.287 1 1.0 (0.85, 1.18) 1.29 (1.04, 1.60) 0.025
Model IIId 1 1.34 (0.92, 1.97) 1.42 (0.96, 2.11) 1.23 (0.82, 1.81) 1.41 (0.97, 2.06) 0.323 1 0.96 (0.80, 1.14) 1.20 (0.94, 1.52) 0.164
Model IVe 1.33 (0.88, 2.00) 1.37 (0.90, 2.08) 1.18 (0.77, 1.80) 1.42 (0.95, 2.12) 0.251 1 0.93 (0.77, 1.11) 1.13 (0.89, 1.44) 0.366
High SBP
Model Ib 1 1.08 (0.26, 4.44) 1.64 (0.40, 6.73) 1.06 (0.23, 4.86) 1.36 (0.33, 5.68) 0.561 1 0.62 (0.34, 1.13) 0.75 (0.30, 1.84) 0.460
Model IIc 1 1.06 (0.26, 4.39) 1.55 (0.37, 6.46) 1.13 (0.25, 5.13) 1.40 (0.34, 5.81) 0.441 1 0.59 (0.33, 1.08) 0.64 (0.26, 1.59) 0.320
Model IIId 1 1.06 (0.28, 4.07) 1.35 (0.33, 5.44) 0.88 (0.20, 3.96) 1.09 (0.28, 4.31) 0.978 1 0.54 (0.28, 1.02) 0.43 (0.14, 1.32) 0.126
Model IVe 1 0.87 (0.23, 3.23) 1.09 (0.28, 4.25) 0.90 (0.20, 3.98) 1.01 (0.26, 3.90) 0.752 1 0.55 (0.28, 1.08) 0.47 (0.15, 1.46) 0.185
High DBP
Model Ib 1 1.58 (0.68, 3.68) 1.69 (0.71, 4.03) 1.34 (0.54, 3.30) 1.34 (0.60, 2.98) 0.429 1 0.98 (0.67, 1.43) 1.05 (0.62, 1.79) 0.863
Model IIc 1 1.55 (0.67, 3.58) 1.59 (0.67, 3.77) 1.33 (0.54, 3.24) 1.32 (0.60, 2.91) 0.471 1 0.98 (0.67, 1.43) 1.02 (0.60, 1.74) 0.942
Model IIId 1 1.34 (0.58, 3.09) 1.26 (0.53, 3.01) 1.05 (0.41, 2.66) 1.04 (0.46, 2.35) 0.235 1 1.08 (0.70, 1.67) 1.13 (0.63, 2.03) 0.682
Model IVe 1 1.73 (0.65, 4.62) 1.73 (0.62, 4.83) 1.31 (0.43, 3.92) 1.39 (0.52, 3.76) 0.366 1 1.11 (0.72, 1.71) 1.10 (0.60, 2.01) 0.743
HTN
Model Ib 1 1.57 (0.73, 3.40) 1.75 (0.81, 3.81) 1.54 (0.68, 3.49) 1.42 (0.68, 2.99) 0.638 1 1.0 (0.70, 1.43) 1.07 (0.65, 1.77) 0.797
Model IIc 1 1.54 (0.71, 3.31) 1.65 (0.76, 3.57) 1.54 (0.69, 3.46) 1.41 (068, 2.93) 0.715 1 1.00 (0.70, 1.43) 1.02 (0.62, 1.69) 0.938
Model IIId 1 1.35 (0.63, 2.90) 1.38 (0.63, 2.99) 1.21 (0.53, 2.79) 1.12 (0.53, 2.37) 0.336 1 1.06 (0.71, 1.59) 1.03 (0.59, 1.81) 0.001**
Model IVe 1 1.61 (0.68, 3.81) 1.70 (0.71, 4.07) 1.41 (0.54, 3.68) 1.42 (0.59, 3.41) 0.592 1 1.06 (0.71, 1.59) 1.03 (0.59, 1.81) 0.911
Note. overweight Z BMI 85the 95th; obesity Z BMI > 95th; abdominal obesity Z waist to height ratio > 0.5; HTN Z > 95th adjusted by age, sex, height.
* Significantly different from > 18e24 month, p Z 0.04.
** Significantly different from > 18e24 month, p Z 0.02.
CASPIAN Z Childhood and Adolescence Surveillance and Prevention of Adult Noncommunicable Disease.
a p for trend are resulted from logistic regression.
b Without adjustment (crude model).
c Adjusted for age, sex, and living place.
d Additionally adjusted for other characteristics including family history of chronic diseases, screen time, physical activity, socioeco-
nomic status, birth order, family size, type of complementary feeding, type of milk, sleeping hours, and BMI (only for HTN).












Table 5 b-coefficients (95% CIs) for anthropometric indices and blood pressure (BP) by categories of breast feeding and birth weight: the CASPIAN-IV study.
BF duration (mo) BW categories (g)
0  6 > 6e12 > 12e18 > 18e24 p trenda < 2500 2500e4000 > 4000 p trenda
BMI (kg/m2)
Model Ib 1 0.52 (0.10, 1.13) 0.81 (0.17, 1.46) 0.42 (0.21, 1.06) 0.40 (0.20, 1) 0.406 1 0.51 (.022, 0.79)* 1.35 (0.92, 1.78)* 0.001***
Model IIc 1 0.55 (0.05, 1.06) 0.60 (0.08, 1.12) 0.43 (0.09e0.95) 0.51 (0.02, 1.00) 0.994 1 0.50 (0.27, 0.73)* 1.18 (0.83, 1.53)* 0.001***
Model IIId 1 0.80 (0.29, 1.31) 0.85 (0.31, 1.39) 0.66 (0.14, 1.19) 0.76 (0.27, 1.26) 0.720 1 0.45 (0.21, 0.69)* 0.95 (0.58, 1.32)* 0.001***
Model IVe 1 0.69 (0.12, 1.26) 0.71 (0.12, 1.30) 0.53 (0.05, 1.11) 0.66 (0.11, 1.22) 0.750 1 0.42 (0.18, 0.67)* 0.89 (0.50, 1.27)* 0.001***
WC (cm)
Model Ib 1 0.77 (0.82, 2.35) 2.06 (0.40, 3.71) 0.56 (1.10, 2.23) 0.96 (0.57, 2.50) 0.810 1 1.03 (0.25, 1.81) 3.44 (2.26, 4.63)* 0.001**
Model IIc 1 0.83 (0.41, 2.07) 1.39 (0.11, 2.67) 0.67 (0.66, 1.9) 1.25 (0.05, 2.44) 0.101 1 1.00 (0.39, 1.62)* 2.77 (1.85, 3.68)* 0.001**
Model IIId 1 0.92 (0.37, 2.22) 1.58 (0.25, 2.91) 0.88 (0.49, 2.26) 1.47 (0.23, 2.70) 0.037 1 0.82 (0.18, 1.46) 2.22 (1.22, 3.22)* 0.001**
Model IVe 1 0.62 (0.84, 2.08) 1.30 (0.20, 2.79) 0.42 (1.11, 1.96) 1.23 (0.17, 2.63) 0.039 1 0.73 (0.06, 1.39) 2.06 (1.02, 3.10)* 0.001**
WHtR
Model Ib 1 0.003 (0.005, 0.010) 0.005 (0.003, 0.01) 0.001 (0.007, 0.010) 0.01 (0.002, 0.012) 0.135 1 0.002 (0.001, 0.006) 0.01 (0.003, 0.02)* 0.002
Model IIc 1 0.003 (0.005, 0.01) 0.007 (0.001, 0.015) 0.002 (0.006, 0.010) 0.006 (0.001, 0.013) 0.073 1 0.002 (0.002, 0.006) 0.009 (0.003, 0.01) 0.005
Model IIId 1 0.005 (0.004, 0.013) 0.008 (0.0003, 0.017) 0.004 (0.005, 0.012) 0.008 (0.0002, 0.16) 0.056 1 0.0004 (0.0004, 0.005) 0.006 (0.004, 0.012) 0.082
Model IVe 0.004 (0.006, 0.013) 0.007 (0.002, 0.017) 0.002 (0.008, 0.012) 0.007 (0.002, 0.016) 0.064 1 0.0004 (0.005, 0.004) 0.004 (0.002, 0.01) 0.240
Wrist
Model Ib 1 0.28 (0.03, 0.53) 0.46 (0.18, 0.74)* 0.28 (0.02, 0.54) 0.28 (0.04, 0.53) 0.885 1 0.27 (0.14, 0.39)* 0.66 (0.47, 0.84)* 0.001**
Model IIc 1 0.26 (0.09, 0.43) 0.31 (0.011, 0.50) 0.28 (0.10, 0.46) 0.29 (0.13, 0.46)* 0.176 1 0.27 (0.18, 0.35)* 0.54 (0.41, 0.67)* 0.001**
Model IIId 1 0.29 (0.12, 0.46)* 0.35 (0.15, 0.55)* 0.28 (0.09, 0.46) 0.32 (0.15, 0.49)* 0.190 1 0.28 (0.19, 0.38)* 0.51 (0.37, 0.66)* 0.001**
Model IVe 00.24 (0.05, 0.42) 0.29 (0.08, 0.51) 0.20 (0.00. 0.40) 0.26 (0.08, 0.44) 0.336 1 0.28 (0.18, 0.38)* 0.50 (0.35, 0.65)* 0.001**
Hip (cm)
Model Ib 1 0.52 (1.38, 2.42) 1.88 (0.37, 4.13) 0.31 (1.70, 2.32) 0.69 (1.16, 2.54) 0.946 1 1.01 (0.05, 1.97) 3.72 (2.30, 5.15)* 0.001**
Model IIc 1 0.67 (0.53, 1.87) 0.87 (0.79, 2.53) 0.34 (1.00, 1.68) 1.13 (0.05, 2.31) 0.107 1 1.02 (0.37, 1.67) 3.12 (2.20, 4.03)* 0.001**
Model IIId 1 0.79 (0.44, 2.02) 1.45 (0.32, 3.21) 0.61 (0.78, 2.00) 1.42 (0.19, 2.64) 0.059 1 0.73 (0.002, 1.14) 2.53 (1.49, 3.57)* 0.001**
Model IVe 1 0.61 (0.76, 1.98) 0.54 (0.94, 2.02) 0.28 (1.23, 1.78) 1.28 (0.08, 2.63) 0.030 1 0.64 (0.10, 1.39) 2.47 (1.40, 3.55)* 0.001**
WhtR
Model Ib 1 0.004 (0.001, 0.007) 0.004 (0.001, 0.006) 0.005 (0.001, 0.009) 0.003 (0.001, 0.006) 0.978 1 0.001 (0.001, 0.003) 0.0004 (0.002, 0.003) 0.682
Model IIc 1 0.003 (0.0002, 0.006) 0.004 (0.001, 0.007) 0.005 (0.001, 0.008) 0.002 (0.0002, 0.005) 0.639 1 0.001 (0.001, 0.003) 0.001 (0.002, 0.003) 0.593
Model IIId 1 0.004 (0.0003, 0.007) 0.003 (0.0003, 0.006) 0.004 (0.0005, 0.008) 0.002 (0.0002, 0.004) 0.377 1 0.002 (0.0002, 0.004) 0.002 (0.002, 0.005) 0.247
Model IVe 1 0.004 (0.00004, 0.007) 0.003 (0.0002, 0.007) 0.004 (0.0002, 0.008) 0.002 (0.0007, 0.004) 0.329 1 0.002 (0.0002, 0.005) 0.002 (0.002, 0.005) 0.335
SBP (mmHg)
Model Ia 1 2.17 (0.51, 3.82) 3.32 (1.56, 5.08)* 1.93 (0.22, 3.65) 1.92 (0.35, 3.50) 0.664 1 0.76 (0.11, 1.63) 1.97 (0.66, 3.29) 0.003
Model IIc 1 2.16 (0.62, 3.70) 2.80 (1.17, 4.42)* 2.03 (0.43, 3.63) 2.09 (0.60, 3.57) 0.889 1 0.73 (0.07, 1.53) 1.34 (0.14, 2.55) 0.026
Model IIId 1 1.42 (0.20, 3.05) 2.18 (0.48, 3.88) 1.46 (0.22, 3.14) 1.62 (0.03, 3.21) 0.540 1 0.15 (0.71, 1.00) 0.29 (1.04, 1.62) 0.663
Model IVe 1 1.25 (0.49, 2.99) 1.92 (0.10, 3.74) 1.35 (0.45, 3.16) 1.50 (0.22, 3.21) 0.490 1 0.10 (0.77, 0.97) 0.25 (1.11, 1.60) 0.719
DBP (mmHg)
Model Ib 1 1.18 (0.30, 2.67) 2.02 (0.46, 3.58) 0.79 (0.71, 2.29) 1.01 (0.40, 2.41) 0.628 1 0.37 (0.41, 1.16) 0.97 (0.11, 2.05) 0.082
Model IIc 1 1.19 (0.23, 2.60) 1.73 (0.24, 3.21) 0.84 (0.59, 2.27) 1.10 (0.25, 2.45) 0.883 1 0.36 (0.41, 1.13) 0.62 (0.41, 1.66) 0.232
Model IIId 1 0.76 (0.73, 2.26) 1.09 (0.48, 2.67) 0.35 (1.18, 1.88) 0.63 (0.81, 2.06) 0.752 1 0.10 (0.73, 0.92) 0.28 (0.84, 1.40) 0.628
Model IVe 1 1.11 (0.45, 2.67) 1.56 (1.00, 3.22) 0.70 (0.89, 2.28) 1.09 (0.42, 2.60) 0.980 1 0.02 (0.88, 0.83) 0.2 (1.11, 1.16) 0.973
* Significantly different from > 18e24 month, p Z 0.04.
** Significantly different from > 18e24 month, p Z 0.02.
BMI Z body mass index; CASPIAN Z Childhood and Adolescence Surveillance and Prevention of Adult Noncommunicable Disease; DBP Z diastolic blood pressure; SBP Z systolic blood
pressure; WC Z waist circumference; WHtR Z waist to height ratio; WhtR Z waist to hip ratio.
a p for trend are resulted from logistic regression.
b Without adjustment (crude model).
c Adjusted for age, sex and living place.
d Additionally adjusted for other characteristics including family history of chronic diseases, screen time, physical activity, socioeco-
nomic status birth order, family size, type of complementary feeding, sleeping hours, BMI (only for SBP and DBP).



























332 S. Djalalinia et alcircumferences increased linearly by higher BW categories
(p for trend < 0.001).
The prevalence (95% CI) of obesity, overweight,
abdominal obesity, and BP in categories of BF duration and
BW are shown in Table 3. The prevalence of general obesity
increased linearly by increasing BW categories (p for trend
< 0.001), while the prevalence of being underweight had a
linear negative association with BW categories (p for trend
< 0.001). Elevated SBP and DBP had no significant associ-
ation with BF and BW categories.
The association of anthropometric and BP measures with
BF duration and BW are presented in Table 4. It shows that
being underweight decreased linearly by increasing BW (p
for trend < 0.001), whereas general obesity had a signifi-
cant association with BW categories, affirming the same
trend based on the crude model and adjusted model for sex
and living place (Model II).
Table 5 shows b-coefficients (95% CIs) for anthropo-
metric indices and BP by categories of BF and BW. BMI and
WC had a significant trend (p for trend < 0.001) of
increasing values with higher BW categories.4. Discussion
The present study presents the association of BF duration
and BW with anthropometric and BP measures in Iranian
children and adolescents. The results showed that BW had
significant associations with increased risk of higher general
obesity and a lower prevalence of being underweight.
We found an inverse association between BW and being
underweight and a positive association of BW with general
obesity in adolescents. We did not document any significant
association between BF duration and BW with anthropo-
metric measures. It should be considered that some
controversial evidence exists on the association of BW with
adulthood body size.19,20
A similar study found a significant association of BW with
adolescents’ body size, weight, and BMI. They reported
that multiple linear regression analyses adjusted for age,
pubertal stage, and gestational age did not show any sig-
nificant effect of BW with adolescents’ weight or BMI.21
Some studies on younger children reported a positive
relationship between BW and childhood BMI.21,22 In a cohort
study, BW was associated with higher insulin levels during
adolescence, and this effect was independent of the cur-
rent weight of adolescents.19 The tracking of BW with
anthropometric indicators of adolescence was investigated
in a large study of twins. It identified a significant positive
relationship of adolescent body size with BW, which was
also influenced by their parents’ body size.23,24
Most related studies emphasized that both genetic pre-
disposition and factors associated with BW were associated
with adult obesity. However, the underlying mechanisms of
association between BW and obesity remain to be
determined.22,24,26
We did not document a significant association of BF and
BW with BP. Our findings are consistent with a previous
study on the effect of neonatal parameters on adolescents’
BP, which did not find a significant relationship of BW with
adolescents’ BP.21,25 However, our findings are not in line
with another study that found a significant negativerelationship of BW with later BP in 11e12-year-olds in Ja-
maica.10 A study on Danish young adult men also detected a
significant inverse relationship of BW with SBP, which was
significant only after adjustment for current BMI of
participants.9
The controversies regarding the relationship between BF
and BW with adolescent anthropometric measures and BP
may be related to a number of factors including age,
ethnicity, maternal glucose tolerance during pregnancy,
changing body composition in adolescence, diet and phys-
ical activity, as well as hormonal changes.19
One of the strengths of this current study was that we
benefited from using a large national representative sample
of Iranian children and adolescents. Moreover measuring
the anthropometric measures and BP as the inputs prior to
our models led to a reduction in confounder effects as far
as possible. The main limitation of this study was its cross-
sectional design, which led to some limitations and recall
bias of parents in gathering information. Although we
adjusted for all potential confounders, residual confound-
ing may still have occurred due to lack of access to birth
status variables.
5. Conclusion
BW was associated with a higher risk of general obesity and
a lower risk of being underweight. However, we did not
detect any significant association for BF with anthropo-
metric measures and BP.
Our findings emphasize paying more attention to the
association between parental consideration on BW and its
subsequent health outcomes. The promotion of screening
strategies in target groups to receive specific preventive
and therapeutic services can help improve present and
future health status. The role of early life factors should be
underscored in early prevention of NCDs, and longitudinal
studies are necessary to assess the possible clinical impacts
of our findings.
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